{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:04:34Z","timestamp":1794701074425,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to evaluate the efficacy and safety of phacoemulsification with intravitreal 3\u2009mg triamcinolone acetonide injection in preventing postoperative inflammation and complications in patients with non-infectious anterior uveitis and panuveitis complicated cataract.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>In this retrospective cohort study, 140 uveitic cataract patients who received phacoemulsification and intraocular lens implantation in Shanxi Eye hospital from January 2018 to January 2020 were reviewed. The IVTA group (51 eyes of 41 patients) received intravitreal injection of 3\u2009mg triamcinolone acetonide (TA) at the end of surgery, and the control group (51 eyes of 41 patients) without injection matched by propensity score matching were enrolled. Outcome measures were best corrected visual acuity (BCVA), anterior chamber inflammation, intraocular pressure, corneal endothelial cell density, central macular thickness and complications within 3\u2009months follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The degree of postoperative anterior chamber inflammation in the IVTA group was lighter than that in the control group (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05). The postoperative logMAR BCVA of anterior uveitis was better and improved more quickly in the IVTA group(<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05). Postoperative time of using corticosteroids was shorter in the IVTA group as compared to the control group (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05). The central macular thickness at postoperative month 1 was statistically significantly lower in the IVTA group (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.05). There were no statistically significant differences between the two groups in postoperative corneal endothelial cell density and intraocular pressure (<jats:italic>P<\/jats:italic>\u00a0&gt;\u20090.05). Two of 51 eyes (3.9%) in the IVTA group and 8 of 51 eyes (15.7%) in the control group had recurrence of uveitis; 6 of 45 eyes (13.3%) in the control group developed cystoid macular edema but none in the IVTA group; 11 of 51 eyes (21.6%) in the IVTA group and 22 of 51 eyes (43.1%) in the control group developed posterior synechiae postoperatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Intraoperative Intravitreal injection of 3\u2009mg TA is an effective and safe adjunctive therapy for preventing postoperative inflammation and complications to promote early recovery for anterior uveitis or panuveitis complicated cataract patients following phacoemulsification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This retrospective cohort study was in accordance with the tenets of the Helsinki Declaration and was approved by the Shanxi Eye Hospital Ethics Committee. Written informed consent was obtained from all participants for their clinical records to be used in this study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02017-y","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T05:04:33Z","timestamp":1622783073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"4","key":"2017_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ajo.2014.06.018","volume":"158","author":"S Mehta","year":"2014","unstructured":"Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158(4):676\u201392. https:\/\/doi.org\/10.1016\/j.ajo.2014.06.018.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2017_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/08820538.2017.1353815","volume":"33","author":"SM Llop","year":"2018","unstructured":"Llop SM, Papaliodis GN. Cataract surgery complications in uveitis patients: a review article. Semin Ophthalmol. 2018;33(1):64\u20139. https:\/\/doi.org\/10.1080\/08820538.2017.1353815.","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"2017_CR3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/bjophthalmol-2016-309047","volume":"101","author":"CJ Chu","year":"2017","unstructured":"Chu CJ, Dick AD, Johnston RL, Yang YC, Denniston AK. UK Pseudophakic macular edema study group. Cataract surgery in uveitis: a multicentre database study. Br J Ophthalmol. 2017;101(8):1132\u20137. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309047.","journal-title":"Br J Ophthalmol"},{"issue":"Pt 5","key":"2017_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/eye.2001.197","volume":"15","author":"PS Suresh","year":"2001","unstructured":"Suresh PS, Jones NP. Phacoemulsification with intraocular lens implantation in patients with uveitis. Eye (Lond). 2001;15(Pt 5):621\u20138. https:\/\/doi.org\/10.1038\/eye.2001.197.","journal-title":"Eye (Lond)."},{"issue":"5","key":"2017_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/09273948.2010.486098","volume":"18","author":"AA Alkawas","year":"2010","unstructured":"Alkawas AA, Hamdy AM, Shahien EA. Intraoperative intravitreal injection of triamcinolone acetonide for cataract extraction in patients with uveitis. Ocul Immunol Inflamm. 2010;18(5):402\u20137. https:\/\/doi.org\/10.3109\/09273948.2010.486098.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"2017_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","volume":"33","author":"AL Buchman","year":"2001","unstructured":"Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289\u20134. https:\/\/doi.org\/10.1097\/00004836-200110000-00006.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"2017_CR7","first-page":"655","volume":"96","author":"MM Morshid","year":"2003","unstructured":"Morshid MM, Zaki HA, Alkawas AA. Intravitreal injection of triamcinolone acetonide in non-infectious uveitis. Bull Ophthalmol Soc Egypt. 2003;96(4):655\u20138.","journal-title":"Bull Ophthalmol Soc Egypt"},{"issue":"2","key":"2017_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/bjo.2006.105601","volume":"91","author":"S Sugita","year":"2007","unstructured":"Sugita S. Intravitreal anti-inflammatory treatment for uveitis. Br J Ophthalmol. 2007;91(2):135\u20136. https:\/\/doi.org\/10.1136\/bjo.2006.105601.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2017_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jcrs.2007.03.030","volume":"33","author":"N Okhravi","year":"2007","unstructured":"Okhravi N, Morris A, Kok HS, et al. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study. J Cataract Refract Surg. 2007;33(7):1278\u201383. https:\/\/doi.org\/10.1016\/j.jcrs.2007.03.030.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2017_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"2017_CR11","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jcrs.2007.04.029","volume":"33","author":"T Dada","year":"2007","unstructured":"Dada T, Dhawan M, Garg S, Nair S, Mandal S. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. J Cataract Refract Surg. 2007;33(9):1613\u20138. https:\/\/doi.org\/10.1016\/j.jcrs.2007.04.029.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2017_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","volume":"69","author":"MC Elze","year":"2017","unstructured":"Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69(3):345\u201357. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.060.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2017_CR13","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1111\/aos.12955","volume":"94","author":"P Mora","year":"2016","unstructured":"Mora P, Gonzales S, Ghirardini S, et al. Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-Centre, prospective, randomized trial. Acta Ophthalmol. 2016;94(6):e390\u20134. https:\/\/doi.org\/10.1111\/aos.12955.","journal-title":"Acta Ophthalmol"},{"key":"2017_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2018.08.041","volume":"196","author":"Y YJi","year":"2018","unstructured":"YJi Y, Hu K, Li C, et al. Outcome and prognostic factors of phacoemulsification cataract surgery in Vogt-Koyanagi-Harada uveitis. Am J Ophthalmol. 2018;196:121\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.08.041.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2017_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0161-6420(94)31310-8","volume":"101","author":"YA Akova","year":"1994","unstructured":"Akova YA, Foster CS. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology. 1994;101(3):473\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(94)31310-8.","journal-title":"Ophthalmology."},{"issue":"1","key":"2017_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/ICU.0000000000000438","volume":"29","author":"MD Conway","year":"2018","unstructured":"Conway MD, Stern E, Enfield DB, Peyman GA. Management of cataract in uveitis patients. Curr Opin Ophthalmol. 2018;29(1):69\u201374. https:\/\/doi.org\/10.1097\/ICU.0000000000000438.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"2017_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/sj.eye.6701585","volume":"19","author":"CK Chan","year":"2005","unstructured":"Chan CK, Fan DS, Chan WM, Lai WW, Lee VY, Lam DS. Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study. Eye (Lond). 2005;19(6):625\u201330. https:\/\/doi.org\/10.1038\/sj.eye.6701585.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2017_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S1607-551X(08)70100-1","volume":"24","author":"YC Chang","year":"2008","unstructured":"Chang YC, Wu WC. Elevation of intraocular pressure after intravitreal injection of triamcinolone acetonide in Taiwanese patients. Kaohsiung J Med Sci. 2008;24(2):72\u20137. https:\/\/doi.org\/10.1016\/S1607-551X(08)70100-1.","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"2017_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3341\/kjo.2005.19.2.122","volume":"19","author":"HY Park","year":"2005","unstructured":"Park HY, Yi K, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol. 2005;19(2):122\u20137. 15988928. https:\/\/doi.org\/10.3341\/kjo.2005.19.2.122.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"2017_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","volume":"126","author":"JE Thorne","year":"2019","unstructured":"Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. Intravitreal triamcinolone vs. Intravitreal dexamethasone implant for the treatment of Uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126(2):283\u201395. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.021.","journal-title":"Ophthalmology."},{"issue":"8","key":"2017_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.ophtha.2008.01.019","volume":"115","author":"BA Kamppeter","year":"2008","unstructured":"Kamppeter BA, Cej A, Jonas JB. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye. Ophthalmology. 2008;115(8):1372\u20135. https:\/\/doi.org\/10.1016\/j.ophtha.2008.01.019.","journal-title":"Ophthalmology."},{"issue":"4","key":"2017_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","volume":"110","author":"PM Beer","year":"2003","unstructured":"Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003;110(4):681\u20136. https:\/\/doi.org\/10.1016\/S0161-6420(02)01969-3.","journal-title":"Ophthalmology."},{"key":"2017_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12824","volume":"1358","author":"SM Whitcup","year":"2015","unstructured":"Whitcup SM, Robinson MR. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis. Ann N Y Acad Sci. 2015;1358:1\u201312. https:\/\/doi.org\/10.1111\/nyas.12824.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2017_CR24","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1080\/09273948.2018.1524498","volume":"27","author":"G Gupta","year":"2019","unstructured":"Gupta G, Ram J, Gupta V, et al. Efficacy of Intravitreal dexamethasone implant in patients of uveitis undergoing cataract surgery. Ocul Immunol Inflamm. 2019;27(8):1330\u20138. https:\/\/doi.org\/10.1080\/09273948.2018.1524498.","journal-title":"Ocul Immunol Inflamm"},{"key":"2017_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2147\/DDDT.S66611","volume":"8","author":"Y Dang","year":"2014","unstructured":"Dang Y, Mu Y, Li L, et al. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients. Drug Des Devel Ther. 2014 Sep 18;8:1441\u20139. https:\/\/doi.org\/10.2147\/DDDT.S66611.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"2017_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/ICU.0b013e32834bbd68","volume":"22","author":"A Sallam","year":"2011","unstructured":"Sallam A, Taylor SR, Lightman S. Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol. 2011;22(6):517\u20132. https:\/\/doi.org\/10.1097\/ICU.0b013e32834bbd68.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"2017_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0002-9394(00)00909-0","volume":"131","author":"MF Estafanous","year":"2001","unstructured":"Estafanous MF, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001;131(5):620\u20135. https:\/\/doi.org\/10.1016\/S0002-9394(00)00909-0.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2017_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/09273948.2016.1206944","volume":"26","author":"SK Ganesh","year":"2018","unstructured":"Ganesh SK, Mistry S. Phacoemulsification with intraocular Lens implantation in pediatric uveitis: a retrospective study. Ocul Immunol Inflamm. 2018;26(2):305\u20132. https:\/\/doi.org\/10.1080\/09273948.2016.1206944.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"2017_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00417-009-1247-7","volume":"248","author":"DH Park","year":"2010","unstructured":"Park DH, Shin JP, Kim SY. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study. Graefes Arch Clin Exp Ophthalmol. 2010;248(5):641\u201350. https:\/\/doi.org\/10.1007\/s00417-009-1247-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02017-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T05:05:18Z","timestamp":1622783118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02017-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02017-y","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was in accordance with the tenets of the Helsinki Declaration and was approved by the Shanxi Eye Hospital Ethics Committee. Written informed consent was obtained from all participants for their clinical records to be used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}